(Q50545726)
Statements
Risk factors predictive of anemia development during telaprevir plus peginterferon/ribavirin therapy in treatment-experienced patients. (English)
1 reference
Stefan Zeuzem
1 reference
Ralph DeMasi
1 reference
Alessandra Baldini
1 reference
Bruce Coate
1 reference
Donghan Luo
1 reference
Joseph Mrus
1 reference
James Witek
1 reference
29 January 2014
1 reference
60
1 reference
6
1 reference
1112-1117
1 reference